Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Rituximab can cause skin issues, but baricitinib may help improve them.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Men with alopecia often feel less confident and have lower wellbeing, needing more support.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Genetic factors can help predict male pattern baldness risk.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Children with atopic diseases have a higher risk of developing alopecia areata.

Certain gene variations may increase the risk and severity of alopecia areata.

People with hidradenitis suppurativa have a higher risk of kidney stones.

Smoking doubles the risk of blindness, and physical exercise helps dyslexic children read better.